MSMurat Sezgin

Murat Sezgin

*This is an algorithmically generated author record based on publicly available information.

Murat Sezgin has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The analysis of unplanned readmissions after left ventricular assist device implantation as bridge-to-transplant

    by Murat Sezgin, Murat Bülent Rabuş, Emre Selçuk, Özge Altaş, Sabit Sarıkaya, Mehmet Balkanay, Mehmet Kaan Kırali

    Background: In this study, we aimed to investigate frequency, patterns, etiologies, and costs of unplanned readmissions after left ventricular assist device implantation. Methods: Between April 2012 and September 2016, 99 unplanned readmissions of a total of 50 consecutive bridge-to-transplant patients (45 males, 5 females; mean age 46.9±10.3 years; range, 19 to 67 years) who were successfully discharged after left ventricular assist device implantation were retrospectively analyzed. Patient demographic data, hemodynamic measurements before implantation, and readmissions after discharge were recorded. Hospitalizations due to major problems which were unable to be managed in routine outpatient clinic were accepted as unplanned readmissions. Survival analysis was performed. Results: The readmission rate was 1.7 per year after discharge. Survival of patients who were readmitted within the first 90 days was found to be significantly lower than those without early readmission. The most common reasons of readmissions during follow-up were major infection (23.2%), neurological dysfunction (22.2%), cardiac causes (12.1%), bleeding (11.1%), and device malfunction (10.1%). Neurological dysfunctions (82,005 USD) and device malfunctions (73,300 USD) caused the highest economic burden. Conclusion: Among patients with a left ventricular assist device, hospital readmissions are common. Development of preventive strategies as well as effective treatment methods focused on longterm adverse events is critical to reduce the frequency and costs of hospital readmissions.

  • The Evaluation of Acute Kidney Injury After Pediatric Heart Surgery By Using “Pediatric RIFLE Criteria”

    by Mehmet Dedemoğlu, Fatih Öztürk, Deniz Günay, Muharrem Dağlı, Ekin Can Çelik, Murat Sezgin, Emre Selçuk, Davut Çekmecelioğlu, Hakan Ceyran


  • Factors Affecting Thrombocytopenia During ECLS After Open Heart Surgery

    by Deniz Çevirme, Rezan Aksoy, Ömer Faruk Şavluk, Emre Gürcü, Adile Ece Altınay, Halide Oğuş, Cüneyt Arkan, Mehmet Yanartaş, Murat Bülent Rabuş

  • Mechano-Chemical Endovenous Ablation of Great Saphenous Vein Insufficiency: Two-Year Results

    by Yücel Özen, Davut Çekmeceli̇oğlu, Sabit Sarikaya, Murat Bülent Rabuş, Ebuzer Aydin, Mehmet Dedemoğlu, Kaan Kirali̇


  • Intestinal Angina Presenting with Superior Mesenteric Artery Aneurysm: Case Report

    by Ahmet Çalişkan, Murat Bülent Rabuş, Feza Eki̇z, Sinan Demi̇rtaş, Mehmet Balkanay

  • A young woman with Takayasu arteritis: surgical and anesthetic management of Bentall procedure in a patient with abdominal aortic aneurysm and renal artery stenosis

    by Ayse Baysal, Murat Bulent Rabus, Saleh Alsalehi, Yasar Gul, Tuncer Kocak, Mehmet Balkanay

    Takayasu’s arteritis (TA) is a rare form of chronic vasculitis involving large arteries. We present the case of a 19-year-old female patient diagnosed with TA, whose medical treatment lasted a period of twelve months. The patient was admitted due to aortic regurgitation and enlargement of...


    • 1 October 2008
      • Vol. 8  (5) , 360-6

    Factors associated with long-term survival following cardiac transplantation.

    by Başar Sareyyüpoğlu, Kaan Kirali, Deniz Göksedef, Murat Bülent Rabuş, Altuğ Tuncer, Vedat Erentuğ, Denyan Mansuroğlu, Cevat Yakut

    By improving short and long-term survivals, cardiac transplantation would be a more realistic curative treatment modality. The aim of this study was to evaluate factors associated with the long-term survival following cardiac transplantations in our center. Forty-four patients were operated on cardiac transplantation between 1989 and November 2006. The study was designed in a retrospective manner and all data were collected from hospital records. Our study population consisted of 16 patients (Group A) who survived >1 month, but died <2 years after cardiac transplantation and 17 patients (Group B) who survived more than 2 years. All patients had triple immunosuppressive therapy (cyclosporine, azathioprine, corticosteroid). Statistical analyses were performed using Fischer's exact and Mann Whitney U tests, and multivariate regression analysis. Survival was analyzed using Cox proportional hazard regression analysis. Group B patients had lower pre-transplant creatinine levels (0.93+/-0.28 mg/dl vs. 1.16+/-0.21 mg/dl, p=0.033) younger donor age (24.5+/-6.3 years vs. 30.1+/-8.1 years, p=0.017) and more male donors (82.3% vs. 50%, p=0.05) as compared with Group A patients. The perioperative and follow-up analysis showed that patients with long-term survival had shorter ischemic time (141.5+/-33.2 min vs. 182.5+/-49.2 min, p=0.007), aortic cross clamp time (65.9+/-10.2 min vs. 83.6+/-7.9 min, p<0.001), less amount of blood transfusion (3.4+/-1.6 units vs. 5.0+/-1.5 units, p=0.01), better NYHA status after operation (1+/-0 vs. 1.63+/-0.72, p=0.014) and less frequent acute rejection episodes (11.8% vs. 68.8%, p<0.001) than those with short-term survival after operation. Cox proportional hazard regression analysis showed higher preoperative creatinine level (HR=42.6, 95% CI 4.67-388.21, p=0.001), acute rejection (HR=4.45, 95% 1.44-13.77, p=0.01), early postoperative functional status (HR=4.84, 95% CI 1.9-12.27, p=0.001) and unsatisfactory rejection surveillance protocol in the first 6 months after transplantation (HR=0.2, 95% CI 0.07-0.67, p=0.008) were prominent factors associated with the long-term survival. The availability of the donor hearts from younger male donors with the shortest ischemic times is identified as the most significant factor improving long-term survival. The main strategy in cardiac transplantation should be shortening ischemic times and applying strict postoperative follow-up.

  • Does Aortic Root Enlargement Impair the Outcome of Patients With Small Aortic Root?

    by Hasan Ardal, Mehmet Erdem Toker, Murat Bulent Rabuş, İbrahim Uyar, Arzu Antal, Mesut Şişmanoğlu, Denyan Mansuroğlu, Kaan Kırali, Cevat Yakut

    Background: Posterior root enlargement procedures provide the implantation of suitable-sized prosthetic valves in patients with a small aortic root to prevent a high postoperative transvalvular gradient. The aim of this study was to evaluate long-term results of the posterior root enlargement. Methods: Between 1985 and 2002, 124 patients underwent aortic valve replacement with a posterior root enlargement. The main indication was a small aortic valve orifice area to patient body surface area (indexed valve area < 0.85 cm2/m2). Fifty-four (44%) patients were male, and 70 (56%) were female with a mean age 39.1 ± 14.3 years. Indications for operation were severe calcified aortic valve stenosis (37.1%), severe aortic insufficiency (25.8%), or combination (37.1%). Seventy-five (60%) patients received double-valve replacement. A pericardial patch was used in 100 patients (80.6%) and a Dacron patch was used in 24 patients. Results: Operative mortality was 6.4% (8 patients). The causes of hospital mortality were low cardiac output syndrome (LCOS) (in 6 patients), cerebrovascular events (in 1 patient) and multiple organ failure (in 1 patient). Multivariate analysis demonstrated concomitant coronary revascularization to be a significant (p = 0.03) predictor for early mortality. There were six (5.4%) late deaths. Cox proportional hazards regression analysis demonstrated LCOS (p = 0.013) and infective endocarditis (p = 0.003) to be significant predictors for late mortality. Atrioventricular block required a permanent pacemaker was observed in 4 patients (3.2%). Conclusions: Posterior aortic root enlargement techniques can be easily applied without additional risks. Long-term survival and freedoms from valve-related complications are satisfactory.


    • 1 December 2003
      • Vol. 3  (4) , 374-5

    [Tricuspid valve endocarditis mimicking cardiac tumor].

    by Denyan Mansuroğlu, Suat Nail Omeroğlu, Murat Bülent Rabuş, Nihan Kayalar, Gökhan Ipek

    • 1 January 2002
      • Vol. 5  (2) , 177-81

    Early- and long-term comparison of the on- and off-pump bypass surgery in patients with left ventricular dysfunction.

    by Kaan Kirali, Murat Bülent Rabus, Necmettin Yakut, Mehmet Erdem Toker, Hasan Basri Erdogan, Mehmet Balkanay, Mete Alp, Cevat Yakut

    The adverse effects of extracorporeal circulation increase the morbidity and mortality risk of coronary bypass surgery, especially in patients with left ventricular dysfunction. The purpose of this study was to provide a comparison of the early and long-term outcome between patient groups with left ventricular dysfunction (LVEFor=15) operated with or without using cardiopulmonary bypass. Fifty-one patients with left ventricular dysfunction, who were operated on between October 1992 and March 1994, were investigated retrospectively. They were divided into two groups: BH-group included 26 patients and cardiopulmonary bypass group had 25 patients. Mean age and risk factors were identical. All patients received one vessel bypass left internal mammary artery to left descending artery. There was no early mortality and perioperative myocardial infarction in either group. In the early postoperative period the need of cardiac support therapy was significantly higher in the cardiopulmonary-bypass group than in the beating heart-group: 32% versus 7.7% (p<0.05). The need for blood products (for fresh frozen plasma 3.63 +/- 2.15u versus 2.5 +/- 1.34u; p = 0.023; for packed red blood cells 1.8 +/- 0.75u versus 1.25 +/- 0.46u; p = 0.048), the extubation time (18.2 +/- 5.5 hours versus 15.3 +/- 3.8 hours; p = 0.03) and the hospital stay (10.64 +/- 3.2 days versus 7.92 +/- 2.25 days; p = 0.001) were higher in the cardiopulmonary bypass -group than in the beating heart-group. Actuarial survival for the beating heart-group was 92.3 +/- 5.2% at 6 years, and for the cardiopulmonary bypass group was 92 +/- 5.4% at 6 years (p = 0.67). In spite of more than four times as many patients in the cardiopulmonary bypass group requiring inotropic support after surgery, survival and cardiac death rates were similar for both groups. Off-pump bypass surgery conserves the blood constituents. The benefits of both techniques to improve the left ventricular performance score and ejection fraction were similar, but postoperative extubation time, length of intensive care unit and hospital stay were reduced significantly in the beating heart group. With these good results of the beating heart coronary bypass surgery and considering its cost effectiveness, we concluded that coronary bypass on a beating heart can be an alternative to cardiopulmonary bypass technique in selective patient groups.